# A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects

> **NCT01548391** · PHASE1 · UNKNOWN · sponsor: **Biotoxtech Co., Ltd** · enrollment: 66 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HX-1171

## Key facts

- **NCT ID:** NCT01548391
- **Lead sponsor:** Biotoxtech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2012-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01548391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01548391, "A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01548391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*